Skip to main content

A revolutionary regenerative therapy for management of chronic inflammatory diseases based on neonatal Mesenchymal Stem Cells

Project description

A stem cell-based treatment for osteoarthritis

Osteoarthritis (OA) is an inflammatory disease that affects both humans and pets. Available OA pharmacological treatments only target the symptoms, have many side effects and are not curative. Scientists of the EU-funded NeoCellBank project propose a regenerative treatment for OA based on stem cells to resolve inflammation and promote endogenous tissue regeneration. The project uses neonatal stem cells, which are superior to adult stem cells due to their low immunogenicity and high anti-inflammatory capacity. This cell-based solution for OA will initially be introduced into the veterinary market before proceeding to human application.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

VETBIOBANK SAS
Net EU contribution
€ 50 000,00
Address
1 Avenue Bourgelat
69280 Marcy-l'etoile
France

See on map

Region
Auvergne-Rhône-Alpes Rhône-Alpes Rhône
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 21 429,00